NeuroMetrix Dividend Yield vs Free Cash Flow Yield Analysis

NURO Stock

USD 4.25 0.03 0.71%

NeuroMetrix financial indicator trend analysis is infinitely more than just investigating NeuroMetrix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroMetrix is a good investment. Please check the relationship between NeuroMetrix Dividend Yield and its Free Cash Flow Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

Dividend Yield vs Free Cash Flow Yield

Dividend Yield vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroMetrix Dividend Yield account and Free Cash Flow Yield. At this time, the significance of the direction appears to have almost identical trend.

The correlation between NeuroMetrix's Dividend Yield and Free Cash Flow Yield is 0.98. Overlapping area represents the amount of variation of Dividend Yield that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of NeuroMetrix, assuming nothing else is changed. The correlation between historical values of NeuroMetrix's Dividend Yield and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Dividend Yield of NeuroMetrix are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Dividend Yield i.e., NeuroMetrix's Dividend Yield and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Dividend Yield

Dividend Yield is NeuroMetrix dividend as a percentage of NeuroMetrix stock price. NeuroMetrix dividend yield is a measure of NeuroMetrix stock productivity, which can be interpreted as interest rate earned on an NeuroMetrix investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 27th of November 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M

	2021	2022	2023	2024 (projected)
Gross Profit	5.9M	5.8M	3.9M	3.8M
Total Revenue	8.3M	8.3M	5.9M	5.6M

Gross Profit Total Revenue

NeuroMetrix fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Preferred Stock Total Equity
Common Stock Shares Outstanding		0.27	-0.16	-0.27	-0.12	0.29	-0.26	0.29	0.22	-0.19	-0.47	-0.27	0.21	-0.05	-0.23	0.24	0.28	-0.44	0.05	-0.21	0.1	-0.26	0.43	-0.23	0.25	-0.18
Total Assets	0.27		-0.32	-0.59	-0.42	0.7	-0.15	-0.08	-0.03	-0.37	-0.45	-0.17	0.38	-0.34	-0.3	0.12	0.98	-0.24	0.08	-0.32	0.15	-0.34	0.53	-0.38	0.69	-0.3
Short Long Term Debt Total	-0.16	-0.32		0.59	0.63	0.09	0.34	0.18	0.29	0.02	-0.33	0.66	-0.02	-0.25	-0.38	-0.61	-0.32	0.15	0.46	-0.35	0.05	0.71	0.28	-0.28	-0.14	-0.39
Other Current Liab	-0.27	-0.59	0.59		0.92	-0.1	0.14	0.05	0.39	0.02	-0.01	0.75	-0.03	-0.19	-0.24	-0.65	-0.62	0.6	0.17	-0.28	0.3	0.78	-0.01	-0.17	-0.46	-0.3
Total Current Liabilities	-0.12	-0.42	0.63	0.92		-0.02	-0.04	0.09	0.68	0.02	-0.16	0.89	-0.03	-0.17	-0.24	-0.58	-0.49	0.67	0.25	-0.3	0.56	0.86	0.12	-0.19	-0.3	-0.3
Total Stockholder Equity	0.29	0.7	0.09	-0.1	-0.02		-0.11	0.13	0.04	-0.32	-0.81	0.11	0.33	-0.76	-0.88	-0.54	0.71	-0.31	0.29	-0.9	0.19	0.03	0.89	-0.93	0.48	-0.88
Other Liab	-0.26	-0.15	0.34	0.14	-0.04	-0.11		-0.35	-0.35	-0.16	0.2	-0.04	0.15	-0.27	-0.09	-0.25	-0.06	-0.15	0.52	0.07	-0.4	-0.05	-0.18	0.07	-0.31	-0.05
Property Plant And Equipment Net	0.29	-0.08	0.18	0.05	0.09	0.13	-0.35		-0.01	0.14	-0.41	0.11	-0.1	0.37	-0.19	-0.04	-0.09	-0.32	-0.36	-0.22	0.02	-0.05	0.35	-0.21	0.52	-0.2
Current Deferred Revenue	0.22	-0.03	0.29	0.39	0.68	0.04	-0.35	-0.01		0.2	-0.34	0.58	-0.2	-0.11	-0.1	-0.14	-0.17	0.56	0.32	-0.15	0.84	0.66	0.28	-0.07	-0.03	-0.11
Net Debt	-0.19	-0.37	0.02	0.02	0.02	-0.32	-0.16	0.14	0.2		-0.05	-0.11	-1.0	0.24	0.19	0.17	-0.46	0.21	-0.1	0.2	0.31	0.13	-0.04	0.2	-0.26	0.21
Retained Earnings	-0.47	-0.45	-0.33	-0.01	-0.16	-0.81	0.2	-0.41	-0.34	-0.05		-0.16	0.03	0.56	0.82	0.45	-0.4	0.27	-0.31	0.81	-0.33	-0.27	-0.99	0.82	-0.49	0.8
Accounts Payable	-0.27	-0.17	0.66	0.75	0.89	0.11	-0.04	0.11	0.58	-0.11	-0.16		0.1	-0.15	-0.24	-0.56	-0.24	0.65	0.31	-0.32	0.55	0.78	0.15	-0.22	-0.11	-0.32
Cash	0.21	0.38	-0.02	-0.03	-0.03	0.33	0.15	-0.1	-0.2	-1.0	0.03	0.1		-0.23	-0.2	-0.16	0.46	-0.24	0.08	-0.21	-0.32	-0.14	0.06	-0.22	0.29	-0.22
Non Current Assets Total	-0.05	-0.34	-0.25	-0.19	-0.17	-0.76	-0.27	0.37	-0.11	0.24	0.56	-0.15	-0.23		0.84	0.73	-0.37	0.1	-0.6	0.8	-0.13	-0.29	-0.64	0.8	0.08	0.82
Non Currrent Assets Other	-0.23	-0.3	-0.38	-0.24	-0.24	-0.88	-0.09	-0.19	-0.1	0.19	0.82	-0.24	-0.2	0.84		0.81	-0.33	0.29	-0.41	0.98	-0.15	-0.28	-0.87	0.98	-0.21	0.99
Other Assets	0.24	0.12	-0.61	-0.65	-0.58	-0.54	-0.25	-0.04	-0.14	0.17	0.45	-0.56	-0.16	0.73	0.81		0.09	-0.07	-0.42	0.8	-0.14	-0.59	-0.5	0.76	0.13	0.83
Cash And Short Term Investments	0.28	0.98	-0.32	-0.62	-0.49	0.71	-0.06	-0.09	-0.17	-0.46	-0.4	-0.24	0.46	-0.37	-0.33	0.09		-0.37	0.07	-0.32	0.0	-0.43	0.49	-0.4	0.66	-0.32
Net Receivables	-0.44	-0.24	0.15	0.6	0.67	-0.31	-0.15	-0.32	0.56	0.21	0.27	0.65	-0.24	0.1	0.29	-0.07	-0.37		0.03	0.18	0.61	0.61	-0.29	0.27	-0.38	0.21
Common Stock Total Equity	0.05	0.08	0.46	0.17	0.25	0.29	0.52	-0.36	0.32	-0.1	-0.31	0.31	0.08	-0.6	-0.41	-0.42	0.07	0.03		-0.36	0.25	0.3	0.33	-0.34	-0.23	-0.42
Non Current Liabilities Total	-0.21	-0.32	-0.35	-0.28	-0.3	-0.9	0.07	-0.22	-0.15	0.2	0.81	-0.32	-0.21	0.8	0.98	0.8	-0.32	0.18	-0.36		-0.24	-0.32	-0.87	0.99	-0.22	0.99
Inventory	0.1	0.15	0.05	0.3	0.56	0.19	-0.4	0.02	0.84	0.31	-0.33	0.55	-0.32	-0.13	-0.15	-0.14	0.0	0.61	0.25	-0.24		0.42	0.31	-0.18	0.01	-0.19
Other Current Assets	-0.26	-0.34	0.71	0.78	0.86	0.03	-0.05	-0.05	0.66	0.13	-0.27	0.78	-0.14	-0.29	-0.28	-0.59	-0.43	0.61	0.3	-0.32	0.42		0.22	-0.22	-0.24	-0.31
Other Stockholder Equity	0.43	0.53	0.28	-0.01	0.12	0.89	-0.18	0.35	0.28	-0.04	-0.99	0.15	0.06	-0.64	-0.87	-0.5	0.49	-0.29	0.33	-0.87	0.31	0.22		-0.88	0.49	-0.85
Total Liab	-0.23	-0.38	-0.28	-0.17	-0.19	-0.93	0.07	-0.21	-0.07	0.2	0.82	-0.22	-0.22	0.8	0.98	0.76	-0.4	0.27	-0.34	0.99	-0.18	-0.22	-0.88		-0.26	0.99
Property Plant And Equipment Gross	0.25	0.69	-0.14	-0.46	-0.3	0.48	-0.31	0.52	-0.03	-0.26	-0.49	-0.11	0.29	0.08	-0.21	0.13	0.66	-0.38	-0.23	-0.22	0.01	-0.24	0.49	-0.26		-0.19
Preferred Stock Total Equity	-0.18	-0.3	-0.39	-0.3	-0.3	-0.88	-0.05	-0.2	-0.11	0.21	0.8	-0.32	-0.22	0.82	0.99	0.83	-0.32	0.21	-0.42	0.99	-0.19	-0.31	-0.85	0.99	-0.19

Click cells to compare fundamentals

NeuroMetrix Account Relationship Matchups

NeuroMetrix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	121.0K	3.8M	2.6M	891.3K	1.0M	1.1M
Total Assets	6.9M	8.0M	24.9M	24.7M	21.4M	17.5M
Other Current Liab	2.1M	1.5M	515.9K	309.9K	586.7K	557.3K
Total Current Liabilities	3.4M	2.3M	1.4M	1.1M	1.2M	1.2M
Total Stockholder Equity	2.5M	5.2M	23.2M	23.4M	20.1M	14.4M
Property Plant And Equipment Net	1.4M	876.2K	673.9K	536.2K	543.6K	599.7K
Net Debt	(2.2M)	(4.8M)	(22.3M)	(3.9M)	(1.5M)	(1.6M)
Retained Earnings	(194.8M)	(196.9M)	(199.2M)	(203.6M)	(210.1M)	(220.6M)
Accounts Payable	725.7K	142.3K	284.0K	368.1K	215.5K	204.7K
Cash	3.1M	5.2M	22.6M	4.3M	1.7M	1.6M
Non Current Assets Total	1.5M	904.7K	700.3K	562.6K	570.0K	541.5K
Non Currrent Assets Other	74.9K	29.7K	28.5K	26.4K	30.4K	31.9K
Other Assets	30.3K	29.7K	721.2K	700.3K	630.3K	600.4K
Cash And Short Term Investments	3.1M	5.2M	22.6M	21.2M	18.0M	12.0M
Net Receivables	488.0K	334.3K	310.8K	646.8K	518.8K	492.9K
Common Stock Total Equity	271.0	738.0	140.0	379.0	341.1	669.34
Liabilities And Stockholders Equity	6.9M	8.0M	24.9M	24.7M	21.4M	17.5M
Non Current Liabilities Total	916.7K	461.4K	306.7K	207.5K	92.5K	87.9K
Inventory	1.2M	1.1M	706.6K	1.6M	1.6M	1.6M
Other Current Assets	2.3M	478.1K	598.4K	645.5K	779.0K	1.5M
Other Stockholder Equity	197.3M	202.1M	222.4M	226.9M	230.0M	241.5M
Total Liab	4.4M	2.7M	1.7M	1.3M	1.3M	1.3M
Property Plant And Equipment Gross	1.4M	183.5K	2.0M	1.2M	1.3M	926.1K
Total Current Assets	5.4M	7.1M	24.2M	24.1M	20.9M	15.7M
Accumulated Other Comprehensive Income	(1.1M)	(1.2M)	(1.2M)	0.0	240.2K	252.2K
Common Stock	140.0	379.0	668.0	778.0	152.0	144.4
Property Plant Equipment	2.4M	273.4K	183.5K	673.9K	606.5K	621.0K
Retained Earnings Total Equity	(191.3M)	(191.0M)	(194.8M)	(196.9M)	(177.2M)	(186.1M)
Net Tangible Assets	6.1M	2.5M	5.2M	23.2M	26.7M	28.0M
Capital Surpluse	196.4M	197.1M	197.3M	202.1M	232.4M	201.3M
Net Invested Capital	2.5M	5.2M	23.2M	23.4M	20.1M	13.4M
Net Working Capital	2.0M	4.8M	22.8M	23.0M	19.6M	12.9M
Capital Stock	141.0	380.0	669.0	779.0	153.0	145.35

Pair Trading with NeuroMetrix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.

Moving against NeuroMetrix Stock

0.49	LH	Laboratory	Pair Corr
0.45	MOH	Molina Healthcare	Pair Corr
0.43	HUM	Humana Inc Fiscal Year End 23rd of January 2025	Pair Corr
0.34	UNH	UnitedHealth Group Fiscal Year End 10th of January 2025	Pair Corr
0.31	XAIR	Beyond Air	Pair Corr

The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.

The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:

How To Invest In NeuroMetrix

Details

Is NeuroMetrix Stock a good investment?

Details

What is NeuroMetrix's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.51)

Revenue Per Share

2.157

Quarterly Revenue Growth

(0.51)

Return On Assets

(0.28)

Return On Equity

(0.43)

The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NeuroMetrix Dividend Yield vs Free Cash Flow Yield Analysis

Dividend Yield vs Free Cash Flow Yield

Dividend Yield vs Free Cash Flow Yield Correlation Analysis

Correlation Coefficient

Dividend Yield

Free Cash Flow Yield

NeuroMetrix fundamental ratios Correlations

NeuroMetrix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

NeuroMetrix fundamental ratios Accounts

Pair Trading with NeuroMetrix

Moving against NeuroMetrix Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Preferred Stock Total Equity	+ 0.99	Non Currrent Assets Other
Total Liab	+ 0.99	Non Current Liabilities Total
Preferred Stock Total Equity	+ 0.99	Non Current Liabilities Total
Preferred Stock Total Equity	+ 0.99	Total Liab
Cash And Short Term Investments	+ 0.98	Total Assets
Non Current Liabilities Total	+ 0.98	Non Currrent Assets Other

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Retained Earnings
Total Liab	- 0.93	Total Stockholder Equity
Non Current Liabilities Total	- 0.9	Total Stockholder Equity
Total Liab	- 0.88	Other Stockholder Equity
Preferred Stock Total Equity	- 0.88	Total Stockholder Equity